| Income Statement |
| Total Revenue | 18.05M |
|
| Revenues (USD) | 18.05M |
| Cost of Revenue | 12.01M |
| Gross Profit | 6.04M |
| Operating Expenses | 3.85M |
| Research and Development Expense | 1.48M |
| Selling, General and Administrative Expense | 2.37M |
| Operating Income | 2.18M |
| Interest Expense | 545.00K |
| Net Income | 1.02M |
| Net Income Common Stock | 1.02M |
| Net Income Common Stock (USD) | 1.02M |
| Consolidated Income | 1.02M |
| Earnings per Basic Share | 0.02 |
| Earnings per Basic Share (USD) | 0.02 |
| Earnings per Diluted Share | 0.02 |
| Earning Before Interest & Taxes (EBIT) | 1.56M |
| Earning Before Interest & Taxes (USD) | 1.56M |
| Weighted Average Shares | 49.23M |
| Weighted Average Shares Diluted | 51.66M |
| Balance Sheet |
| Cash and Equivalents | 23.54M |
| Cash and Equivalents (USD) | 23.54M |
| Trade and Non-Trade Receivables | 19.47M |
| Current Assets | 66.52M |
| Property, Plant & Equipment Net | 15.43M |
| Total Assets | 106.04M |
| Debt Current | 571.00K |
| Total Debt | 34.27M |
| Current Liabilities | 8.69M |
| Debt Non-Current | 33.70M |
| Total Liabilities | 43.25M |
| Accumulated Retained Earnings (Deficit) | -123.82M |
| Accumulated Other Comprehensive Income | 6.06M |
| Shareholders Equity | 62.78M |
| Shareholders Equity (USD) | 62.78M |
| Assets Non-Current | 39.52M |
| Total Debt (USD) | 34.27M |
| Inventory | 15.01M |
| Liabilities Non-Current | 34.56M |
| Trade and Non-Trade Payables | 8.48M |
| Tax Assets | 2.17M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 448.00K |
| Net Cash Flow from Financing | 7.24M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.30M |
| Capital Expenditure | -1.08M |
| Issuance (Purchase) of Equity Shares | 1.15M |
| Issuance (Repayment) of Debt Securities | 6.09M |
| Net Cash Flow from Investing | -1.79M |
| Net Cash Flow from Operations | 2.42M |
| Effect of Exchange Rate Changes on Cash | -486.00K |
| Share Based Compensation | 203.00K |